NM_201596.3:c.333+43556G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_201596.3(CACNB2):​c.333+43556G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.158 in 93,324 control chromosomes in the GnomAD database, including 884 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.16 ( 884 hom., cov: 26)

Consequence

CACNB2
NM_201596.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.289

Publications

15 publications found
Variant links:
Genes affected
CACNB2 (HGNC:1402): (calcium voltage-gated channel auxiliary subunit beta 2) This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Feb 2013]
CACNB2 Gene-Disease associations (from GenCC):
  • Brugada syndrome 4
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Laboratory for Molecular Medicine
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.26 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_201596.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
NM_201596.3
MANE Select
c.333+43556G>A
intron
N/ANP_963890.2
CACNB2
NM_201590.3
MANE Plus Clinical
c.171+43556G>A
intron
N/ANP_963884.2
CACNB2
NM_201597.3
c.333+43556G>A
intron
N/ANP_963891.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB2
ENST00000324631.13
TSL:1 MANE Select
c.333+43556G>A
intron
N/AENSP00000320025.8
CACNB2
ENST00000377329.10
TSL:1 MANE Plus Clinical
c.171+43556G>A
intron
N/AENSP00000366546.4
CACNB2
ENST00000352115.10
TSL:1
c.333+43556G>A
intron
N/AENSP00000344474.6

Frequencies

GnomAD3 genomes
AF:
0.158
AC:
14769
AN:
93212
Hom.:
882
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.0573
Gnomad AMI
AF:
0.245
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.118
Gnomad EAS
AF:
0.0891
Gnomad SAS
AF:
0.185
Gnomad FIN
AF:
0.221
Gnomad MID
AF:
0.213
Gnomad NFE
AF:
0.212
Gnomad OTH
AF:
0.190
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.158
AC:
14777
AN:
93324
Hom.:
884
Cov.:
26
AF XY:
0.162
AC XY:
7480
AN XY:
46132
show subpopulations
African (AFR)
AF:
0.0572
AC:
1765
AN:
30860
American (AMR)
AF:
0.268
AC:
2604
AN:
9700
Ashkenazi Jewish (ASJ)
AF:
0.118
AC:
172
AN:
1452
East Asian (EAS)
AF:
0.0884
AC:
441
AN:
4990
South Asian (SAS)
AF:
0.185
AC:
535
AN:
2894
European-Finnish (FIN)
AF:
0.221
AC:
1437
AN:
6498
Middle Eastern (MID)
AF:
0.218
AC:
27
AN:
124
European-Non Finnish (NFE)
AF:
0.212
AC:
7418
AN:
34976
Other (OTH)
AF:
0.186
AC:
221
AN:
1190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
672
1344
2015
2687
3359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0989
Hom.:
1246
Bravo
AF:
0.0963

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
5.3
DANN
Benign
0.74
PhyloP100
0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17691888; hg19: chr10-18734528; API